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Catalytic Asymmetric Synthesis of Diazabicyclo[3.1.0]hexanes by 1,3-Dipolar 
Cycloaddition of Azomethine Ylides with Azirines.  
Alba Molina,a Sergio Díaz-Tendero, c,b Javier Adrio, a,b* Juan C. Carretero a,b* 
Substituted 1,3-diazabicyclo[3.1.0]hexanes with two contiguous 
quaternary stereocentres are readily prepared by catalytic 
asymmetric [3+2] cycloaddition of -substituted iminoesters with 
azirines. High diastereoselectivities and enantioselectivities (up to 
98% ee) are achieved using CuI/(R)-Fesulphos as catalytic system. 
Aziridine alkaloids are highly valuable heterocyclic compounds 
extensively used as synthetic intermediates.1 In addition, this 
structural fragment is present in a variety of drugs and 
biologically active natural products.2 Specifically, the 
diazabicyclo[3.1.0]hexane scaffold is found in several 
compounds with interesting biological properties such as 
Mitomycins3 (antibiotic, antitumor), Albomitomycin C4 
(neoplasm inhibitor) or Imexon5 (immunosuppressant, Figure 
1). However, the existing methodologies for the 
enantioselective preparation of aziridinoimidazolines are 
cumbersome and usually require multistep sequences starting 
from enantioenriched materials.6  
The catalytic asymmetric 1,3-dipolar cycloaddition of 
azomethine ylides is arguably one of the most efficient and 
atom economic procedures for the enantioselective 
preparation of pyrrolidine type heterocycles.7 In the last two 
Figure 1: Biologically active aziridinopyrrolidines 
decades a great effort has been made to expand the scope of 
this reaction to a variety of dipolarophile and azomethine 
partners.8 As a result, the cycloaddition between iminoesters 
and activated olefins has witnessed an astonishing progress in 
enantioselective pyrrolidine synthesis.9 In this context, we and 
others have recently demonstrated that taking advantage of the 
strain ring release during the [3+2] cycloaddition, sterically 
hindered strained dipolarophiles, such as trisubstituted 
cyclobutenones10 or cyclopropenes,11 are suitable substrates in 
this reaction.  
In contrast, the use of imines as heterodipolarophiles, leading 
to the formation of imidazolines, has been much less studied. 
These scarce reports on catalytic asymmetric azomethine ylide-
imine cycloaddition typically involve aldehyde derived imines 
(Scheme 1).12 
We envisaged that by strain release sterically hindered azirines 
could participate as dipolarophiles in this transformation paving 
the way to the preparation of enantioenriched 
diazabicyclo[3.1.0]hexane analogues with potential biological 
interest (Scheme 1). However, these three membered 
azaheterocycles have been barely used as dipolarophiles in 1,3-
dipolar cycloadditions13 and, as far as we are aware, there are 
no reported examples of their use in catalytic asymmetric 1,3-
dipolar cycloadditions of azomethine ylides.  
Scheme 1: Imines in catalytic asymmetric 1,3-dipolar cycloaddition 
of azomethine ylides 
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In order to test the feasibility of azirines as dipolarophiles in the 
1,3-dipolar cycloaddition of azomethine ylides, 3-phenyl-2H-
azirine 1a and glycine derived iminoester 2 were chosen as 
model substrates. Under conditions commonly used by our 
research group with other dipolarophiles (Cu(CH3CN)4 as metal 
source, DTBM-Segphos (6) as ligand, and KOtBu as base in THF)14 
the expected cycloadduct 4 was obtained with high conversion 
and excellent diastereocontrol (only the endo isomer was 
observed by 1H-NMR, Table 1, entry 1). However, the standard 
silica gel chromatography purification of the product led to the 
formation of two diastereoisomers by silica gel promoted 
epimerization of the aminal chiral centre.15 When the 
purification was performed by chromatography on Et3N 
deactivated silica, the diazabicycle 4 could be isolated as a single 
diastereomer with moderate yield and low enantioselectivity 
(20% ee, entry 1). Other metal sources, chiral ligands, bases or 
solvents did not improve the initial results (entries 2-5). To try 
to improve the chemical stability of the adducts we next 
evaluated the cycloaddition of the alanine derived iminoester 
3a, which would lead to the formation of a diazabicycle with a 
quaternary stereocentre at C-4 (5a). Pleasingly, with DTBM-
Segphos (6) as ligand, KOtBu as base in CH2Cl2, the reaction took 
place with similar yield (46%), excellent endo-
diastereoselectivity and improved enantiocontrol (5a, 68% ee, 
entry 6). Similar results were obtained with the less bulky 
Segphos ligand 7 (entry 7). Interestingly, very high 
enantioselectivity was achieved in the presence of (R)-
Fesulphos ligand 8 (76%, 95% ee, entry 8). Disappointingly, a 
significant drop in conversion and asymmetric induction was 
observed when the catalyst loading was reduced to 5 mol% 
(entry 9). 
Table 1: Optimization of the reaction conditions 
aCu(CH3CN)4PF6. bIsolated yield after chromatographic purification. cee determined 
by HPLC. d5 mol% of catalyst. 
Table 2: Scope regarding the substitution at the iminoester 
aIsolated yield after chromatographic purification. bee determined by HPLC.  cThe 
reaction was carried out at -20°C. 
With these optimized reaction conditions in hand, we next 
investigated the scope of the 1,3-dipolar cycloaddition with 
regard to the substitution at the azomethine ylide. As depicted 
in Table 2, different aromatic alanine derived iminoesters were 
initially investigated. The reaction of meta or para substituted 
iminoesters resulted in good yields, almost complete endo-
diastereoselectivity and high enantioselectivity (adducts 5b and 
5c), while a lower enantioselectivity was obtained from an 
ortho-substituted substrate (product 5d, 70% ee). Electron 
deficient aromatic iminoesters, bearing fluoro (3e), cyano (3f), 
ester (3g) or trifluoromethyl (3h) groups, as well as the thienyl 
iminoester 3i, proved  also to be excellent substrates in this 
transformation (90-98% ee). The reaction of aryl iminoesters 3j 
and 3k having stronger electron-donating groups such as OMe 
and SMe afforded the corresponding adducts 5j and 5k in 
moderate yields and good enantioselectivities, although a 2:1 
mixture of diastereoisomers was obtained using the para-
anisaldehyde derivative 3j (adduct 5j). 
Not unexpectedly no cycloaddition was observed with the 
highly sterically demanding benzophenone-derived alanine 
ketimine ester 3l. In contrast, the reaction with the less bulky 
glycine analogue 3m afforded the adduct 5m, having a 
Entry R1 [M] L* base solvent yield(%)b 
ee 
(%) 
1 H CuPF6[a] 6 KOtBu THF 52 20 
2 H CuPF6[a] 6 KOtBu CH2Cl2 54 24 
3 H CuPF6[a] 6 Et3N CH2Cl2 -- -- 
4 H AgOAc 6 KOtBu CH2Cl2 10 -- 
5 H CuPF6[a] 8 KOtBu CH2Cl2 65 24 
6 Me CuPF6[a] 6 KOtBu CH2Cl2 46 68 
7 Me CuPF6[a] 7 KOtBu CH2Cl2 34 69 
8 Me CuPF6[a] 8 KOtBu CH2Cl2 76 95 
9 d Me CuPF6[a] 8 KOtBu CH2Cl2 58 79 
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quaternary stereocentre at C-2, with moderate 
enantioselectivity (67% ee). 
To extend the scope of this cycloaddition, the effect of the 
substitution at the alpha position of the iminoester was also 
investigated. Schiff bases prepared from other amino esters 
such as ethyl aminobutanoate (3n), ethyl phenylalaninate (3o), 
ethyl amino-4-phenylbutanoate (3p) or the imino ester 3q 
bearing an alkenyl substituent worked well (adducts 5n-5q, 
89%-93% ee). In contrast, the methionine ethyl ester derivative 
afforded a poor enantioselectivity (5r, 30% ee).  
The scope of the reaction regarding the substitution at the 
azirine partner is summarized in Table 3. Under the optimized 
reaction conditions the reaction proceeded smoothly with 2-
arylazirines regardless of the para or meta position of the 
methyl substituent (Table 3, substrates 5s and 5t). Substrates 
bearing halogen substituents (1u and 1v) led to the 
corresponding diazabicycles with good yield (82-84%) and 
excellent enantioselectivities (92-97% ee). However, a lower 
reactivity albeit similar enantioselectivity was observed with 2-
arylazirines bearing strong electron donating substituents, (5w, 
35%, 90% ee).  
Table 3: Scope regarding  
aIsolated yield after chromatographic purification. bee determined by HPLC. 
Next, we set out to study the behaviour of racemic 2,3-
disubstituted azirines in this cycloaddition (Table 4). Thus, the 
reaction of diphenylazirine 1g with alanine derived iminoester 
3a afforded a single adduct 6a with 37% yield and excellent 
enantioselectivity (98% ee). This outcome strongly suggests that 
an efficient kinetic resolution process has took place. 
Disappointingly, the unreacted azirine could not be recovered, 
likely due to its instability. Next, a variety of disubstituted 
racemic azirines were tested in the cycloaddition affording 
similarly a single adduct bearing four stereocentres with 
moderate to excellent ee´s (Table 4, adducts 6g, 6i, 6s and 6t).  
Table 4: Cycloaddition of racemic diarylazirines 1g and 1h 
aIsolated yield after chromatographic purification. bee determined by HPLC. 
The relative configuration of diazabicycles 5 and 6 was 
unambiguously determined by X-ray diffraction of racemic 5r 
and 6s.16 The absolute configuration of the diazabicycles was 
tentatively established based on the model previously reported 
by us for CuI/(R)-Fesulphos catalysed cycloadditions17 and 
confirmed by comparison of experimentally measured and 
simulated by DFT circular dichroism of (+)-6s (see ESI for 
details). Thus, according to this model the approach of the 
azirine would occur by the less hindered face of the key chiral 
metallodipole, avoiding the steric interaction with the bulky tBu 
group of the P,S-ligand (Scheme 2). Accordingly, the 2,3-
disubstituted azirines of (R) configuration would react at a 
faster rate than the (S) enantiomers avoiding the steric 
interaction between the azirine substituent and the tBu group 
of the copper catalyst (Scheme 2).
Scheme 2: Proposed stereochemical model. 
In conclusion, we have developed a practical copper catalyzed 
asymmetric 1,3-dipolar cycloaddition of azomethine ylides with 
azirines. The use of CuI/(R)-Fesulphos as catalyst allows the 
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preparation of diazabicyclo[3.1.0]hexanes bearing up to four 
stereocentres with almost complete endo-diastereoselectivity 
and excellent enantioselectivities. 
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